Research Now launches gastrointestinal panel
The panel consists of people who have been diagnosed with one or more of the following: Crohn’s disease, gastroesophageal reflux disease (GERD), anemia, constipation, Hepatitis B, Hepatitis C and irritable bowel syndrome (IBS).
This is the sixth market research panel based around therapeutic areas to be launched by the company.

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments